{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:13:43Z","timestamp":1774538023196,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.05.120","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T18:20:41Z","timestamp":1528827641000},"page":"4404-4424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The health economics of cholera: A systematic review"],"prefix":"10.1016","volume":"36","author":[{"given":"Amber","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela H.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittal","family":"Mogasale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilm","family":"Quentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.120_b0005","unstructured":"Fact sheet #107: Cholera: Key Facts. July 2015. at Available at <http:\/\/www.who.int\/mediacentre\/factsheets\/fs107\/en\/>."},{"key":"10.1016\/j.vaccine.2018.05.120_b0010","first-page":"433","article-title":"Weekly epidemiological record: Cholera, 2015","volume":"38","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.05.120_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0020","unstructured":"Water and Sanitation: Current Status & Progress on Water, July 2017. At <http:\/\/data.unicef.org\/topic\/water-and-sanitation\/drinking-water\/> [accessed 11\/20, 2017]."},{"key":"10.1016\/j.vaccine.2018.05.120_b0025","unstructured":"Water and Sanitation: Current Status & Progress on Sanitation, July 2017. At <http:\/\/data.unicef.org\/topic\/water-and-sanitation\/sanitation\/> [accessed 11\/20, 2017]."},{"key":"10.1016\/j.vaccine.2018.05.120_b0030","first-page":"477","article-title":"Cholera vaccines: WHO position paper \u2013 August 2017","volume":"34","author":"World Health Organization","year":"2017","journal-title":"Week Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.05.120_b0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2471\/BLT.16.175166","article-title":"Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings","volume":"95","author":"Hsiao","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.05.120_b0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.05.120_b0045","unstructured":"Comparison of Currently Manufactured Oral Cholera Vaccines; 2016. <http:\/\/www.stopcholera.org\/>."},{"key":"10.1016\/j.vaccine.2018.05.120_b0050","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2214-109X(16)00037-1","article-title":"A second affordable oral cholera vaccine: implications for the global vaccine stockpile","volume":"4","author":"Desai","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2018.05.120_b0055","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4161\/hv.28885","article-title":"Economics and financing of vaccines for diarrheal diseases","volume":"10","author":"Bartsch","year":"2014","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2018.05.120_b0060","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4161\/hv.29352","article-title":"Systematic review of the economic value of diarrheal vaccines","volume":"10","author":"Rheingans","year":"2014","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2018.05.120_b0065","article-title":"Economic burden of cholera in the WHO african region","volume":"9","author":"Kirigia","year":"2009","journal-title":"BMC Int Health Hum Rights"},{"key":"10.1016\/j.vaccine.2018.05.120_b0070","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1017\/S0950268811000513","article-title":"Costs of illness due to endemic cholera","volume":"140","author":"Poulos","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.05.120_b0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/1471-2334-13-518","article-title":"Cost-of-illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective","volume":"13","author":"Sarker","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","author":"Jeuland","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2018.05.120_b0085","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.vaccine.2013.10.021","article-title":"Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh","author":"Khan","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.120_b0090","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/infdis\/jit233","article-title":"Strategy, demand, management, and costs of an international cholera vaccine stockpile","volume":"208","author":"Maskery","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001844","article-title":"Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar","volume":"6","author":"Schaetti","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10640-011-9508-4","article-title":"Giving stated preference respondents \u201cTime to Think\u201d: results from four countries","volume":"51","author":"Cook","year":"2012","journal-title":"Environ Resour Econ"},{"key":"10.1016\/j.vaccine.2018.05.120_b0105","series-title":"Estimating the private benefits of vaccination against cholera using travel costs","author":"Jeuland","year":"2008"},{"key":"10.1016\/j.vaccine.2018.05.120_b0110","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.vaccine.2009.02.104","article-title":"Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs","volume":"27","author":"Jeuland","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.120_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1524-4733.2007.00220.x","article-title":"Private demand for cholera vaccines in Hue, Vietnam","volume":"11","author":"Kim","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2018.05.120_b0120","first-page":"659","article-title":"Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience (Provisional abstract)","author":"Kim","year":"2011","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2018.05.120_b0125","unstructured":"Lopez-Gigosos R, Garcia-Fortea P, Calvo MJ, Reina E, Diez-Diaz R, Plaza E. Effectiveness and economic analysis of the whole cell\/recombinant B subunit (WC\/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea (Provisional abstract). BMC Infect Dis, article 65."},{"key":"10.1016\/j.vaccine.2018.05.120_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1708-8305.2008.00270.x","article-title":"Cost-benefit of WC\/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea","volume":"16","author":"Lundkvist","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2018.05.120_b0135","article-title":"An optimal cost effectiveness study on Zimbabwe cholera seasonal data from 2008\u20132011","author":"Sardar","year":"20138","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2018.05.120_b0140","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.worlddev.2012.03.004","article-title":"Setting priorities, targeting subsidies among water, sanitation, and preventive health interventions in developing countries","volume":"40","author":"Whittington","year":"2012","journal-title":"World Dev"},{"key":"10.1016\/j.vaccine.2018.05.120_b0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/14712598.2.6.665","article-title":"3rd World Congress on Vaccines and Immunisation","volume":"2","author":"Babiuk","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2018.05.120_b0150","unstructured":"Bureau of Labor Statistics. Consumer Price Index Inflation Calculator. n.d."},{"key":"10.1016\/j.vaccine.2018.05.120_b0155","unstructured":"The Cochrane Collaboration. Chapter 15: Incorporating economics evidence. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions version 510 updated March 2011."},{"key":"10.1016\/j.vaccine.2018.05.120_b0160","doi-asserted-by":"crossref","first-page":"e3343","DOI":"10.1371\/journal.pntd.0003343","article-title":"Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study","volume":"8","author":"Dimitrov","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0165","unstructured":"Lopez A, DeRoeck D, Maskery B, et al. Country investment case study on cholera vaccination: Bangladesh; 2013."},{"key":"10.1016\/j.vaccine.2018.05.120_b0170","unstructured":"Levin A, Maskery B, DeRoeck D, et al. An investment case for the accelerated introduction of oral cholera vaccines. International Vaccine Institute; 2012."},{"key":"10.1016\/j.vaccine.2018.05.120_b0175","unstructured":"Oxford Economics. Economic impact of a cholera epidemic on Mozambique and Bangladesh, June 2010."},{"key":"10.1016\/j.vaccine.2018.05.120_b0180","first-page":"490","article-title":"Consumption of medications during the cholera epidemic in Douala, Cameroon (2004)","volume":"67","author":"Gu\u00e9vart","year":"2007","journal-title":"Med Trop"},{"key":"10.1016\/j.vaccine.2018.05.120_b0185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.279.7.521","article-title":"Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis","volume":"279","author":"Naficy","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2018.05.120_b0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-3156.2003.01189.x","article-title":"Strengthening health services to control epidemics: empirical evidence from Guinea on its cost-effectiveness","volume":"9","author":"Van Damme","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2018.05.120_b0195","first-page":"77","article-title":"Efficiency of hospital cholera treatment in Ecuador","volume":"5","author":"Creamer","year":"1999","journal-title":"Revista Panamericana de Salud Publica\/Pan Am J Public Health"},{"key":"10.1016\/j.vaccine.2018.05.120_b0200","first-page":"9","article-title":"The economic impact of the cholera epidemic, Peru, 1991","volume":"13","author":"Pan American Health Organization","year":"1992","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.vaccine.2018.05.120_b0205","first-page":"569","article-title":"Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization","volume":"63","author":"de Zoysa","year":"1985","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.05.120_b0210","first-page":"341","article-title":"Use of rice-based oral rehydration solution in a large diarrhoea treatment centre in Bangladesh: In-house production, use and relative cost","volume":"97","author":"Islam","year":"1994","journal-title":"J Trop Med Hygiene"},{"key":"10.1016\/j.vaccine.2018.05.120_b0215","first-page":"343","article-title":"Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera","volume":"76","author":"Murray","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.05.120_b0220","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1016\/j.vaccine.2015.09.088","article-title":"Optimized oral cholera vaccine distribution strategies to minimize disease incidence: a mixed integer programming model and analysis of a Bangladesh scenario","volume":"33","author":"Smalley","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.120_b0225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4269\/ajtmh.14-0159","article-title":"Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator (Provisional abstract)","author":"Troeger","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.05.120_b0230","first-page":"1947","article-title":"Cholera vaccination: a decision analysis","volume":"146","author":"MacPherson","year":"1992","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2018.05.120_b0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IDR.S10339","article-title":"Review of oral cholera vaccines: efficacy in young children","volume":"4","author":"Masuet Aumatell","year":"2011","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2018.05.120_b0240","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.120_b0245","doi-asserted-by":"crossref","first-page":"e0005124","DOI":"10.1371\/journal.pntd.0005124","article-title":"Oral cholera vaccination delivery cost in low- and middle-income countries: an analysis based on systematic review","volume":"10","author":"Mogasale","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.05.120_b0255","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/605033","article-title":"Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries","volume":"200","author":"Atherly","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.120_b0260","unstructured":"Brenzel L, Wolfson LJ, Fox-Rushby J, Miller M, Halsey NA. Vaccine-preventable Diseases. In: Jamison DT, Breman JG, Measham AR, et al., editors, Disease control priorities in developing countries. Washington (DC): World Bank, The International Bank for Reconstruction and Development\/The World Bank Group; 2006."},{"key":"10.1016\/j.vaccine.2018.05.120_b0265","unstructured":"Cost-effective: Immunisation is one of the most cost-effective ways to save lives, improve health and ensure long-term prosperity. n.d. Available at <http:\/\/www.gavi.org\/about\/value\/cost-effective\/> [Accessed 22 Dec, 2016]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T16:46:03Z","timestamp":1530031563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":53,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18307990"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.120","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733458916.793558863","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The health economics of cholera: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}